A new analysis report on the vascular graft market which is forecasted between 2021 and 2028 has been published by Knowledge Sourcing Intelligence. The primary factor bolstering the rise of the vascular graft market is the ageing p...
A new analysis report on the vascular graft market which is forecasted between 2021 and 2028 has been published by Knowledge Sourcing Intelligence.
The primary factor bolstering the rise of the vascular graft market is the ageing population. Furthermore, the growing prevalence of kidney diseases is also driving the market growth. For instance, according to the National Institute of Diabetes and Digestive Kidney Diseases, over 37 million Americans, that is more than one in seven U.S. adults, are affected with chronic kidney disease (CKD) Also according to the CDC, the prevalence of chronic kidney disease is highest among individuals aged 65 and older, affecting 38% of this demographic, followed by a 12% prevalence among individuals aged 45 to 64 years.
The vascular graft market was valued at US$6.372 billion in 2021 and is anticipated to grow at a CAGR of 6.42% over the forecasted period to reach a market size of US$9.851 billion in 2028.
A vascular graft is a tube-shaped medical tool employed in vascular surgery, serving to substitute, bypass and repair damaged of diseased blood vessels within the body. It's designed to redirect or restore proper blood flow within the body. They are typically made from synthetic, semi-synthetic and from natural materials. Vascular grafts play a critical role in the treatment of intracranial aneurysms, renal diseases and for cardiovascular care.
The market is observing numerous product launches and advancements. For instance, in May 2022, UC Davis secured a $3 million grant from CIRM for the development of an innovative intelligent vascular graft designed specifically for hemodialysis in individuals. This device integrates a unique molecule to direct the body's stem cells, with the objective of preventing failures in synthetic vascular grafts. Also, in September 2021, Terumo Aortic announced the launch of the global surgical graft study, PANTHER, which encompasses a thorough evaluation of the company's knitted and woven surgical grafts, along with cardiovascular patches.
The vascular graft market, based on source, is segmented into three main categories namely Synthetic, Semi-Synthetic and Natural. Synthetic materials are commonly used in vascular grafts due to their durability, resistance to infection, and ability to withstand high pressures.
The vascular graft market is segmented based on indications into four key categories, namely renal disease, cardiovascular, aneurysms and others. Vascular grafts are employed in cardiovascular procedures to bypass or repair diseased or blocked blood vessels, restoring proper blood flow and reducing the risk of cardiovascular complications.
The vascular graft market, based on its end user, is segmented into two main categories namely hospitals and clinics and ambulatory surgical centers. Hospitals and clinics employ vascular grafts in surgical procedures to support proper blood circulation and assist in patients' recovery.
North America is poised to experience substantial growth. The rise in the ageing population coupled with the Increasing prevalence of vascular diseases in regions like the United States and Canada has propelled the growth of the vascular graft market in the region. For instance, according to data from the United States Census Bureau, between 1920 and 2020, the U.S. population aged 65 and above expanded nearly five times more rapidly than the overall population growth. In 2020, the demographic aged 65 and over comprised 55.8 million individuals, representing 16.8% of the entire United States population.
The research includes coverage of Getinge Group, W.L. Gore & Associates, B. Braun Melsungen AG, LeMaitre Vascular Inc., Abbott Laboratories, Cook Medical, Terumo Medical Corporation, Cryolife, Medtronic PLC, Endologix Inc. as the significant market players in the vascular graft market.
View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/global-vascular-graft-market
The market analytics report segments the vascular graft market using the following criteria:
- By Source
- Synthetic
- Semi-Synthetic
- Natural
- By Indication
- Cardiovascular
- Renal Disease
- Aneurysms
- Others
- By End-User
- Hospital & Clinics
- Ambulatory Surgical Centers
- By Geography
- North America
- United States
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- Others
- Asia Pacific
- Japan
- China
- India
- South Korea
- Indonesia
- Taiwan
- Thailand
- Others
- North America
- Bone Graft Substitute Market Size
- Vascular Graft Market Size
- Global Vascular Access Systems Market Size
Have questions?
More Press Releases
Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031
The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.
Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%
The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.
Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031
The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.